...
rani-img

Rani Therapeutics Holdings Inc, Common Stock

RANI

NMQ

$1.42

+$0.02

(1.43%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$81.97M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
492.35K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.11
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.3 L
$8.75 H
$1.42

About Rani Therapeutics Holdings Inc, Common Stock

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameRANISectorS&P500
1-Week Return-10.69%-0.94%-2.6%
1-Month Return-31.73%-5.08%-1.08%
3-Month Return-34.86%-10.62%3.45%
6-Month Return-65.45%-6.18%8.57%
1-Year Return-56.97%1.98%24.3%
3-Year Return-92.37%-0.93%25.58%
5-Year Return-87.09%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue979.00K462.00K2.72M--[{"date":"2019-12-31","value":36.03,"profit":true},{"date":"2020-12-31","value":17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue---1.31M822.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.65,"profit":true}]
Gross Profit979.00K462.00K2.72M(1.31M)(822.00K)[{"date":"2019-12-31","value":36.03,"profit":true},{"date":"2020-12-31","value":17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-48.29,"profit":false},{"date":"2023-12-31","value":-30.25,"profit":false}]
Gross Margin100.00%100.00%100.00%--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses28.04M17.01M54.32M63.45M66.10M[{"date":"2019-12-31","value":42.43,"profit":true},{"date":"2020-12-31","value":25.73,"profit":true},{"date":"2021-12-31","value":82.17,"profit":true},{"date":"2022-12-31","value":95.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(27.07M)(16.54M)(51.60M)(63.45M)(66.10M)[{"date":"2019-12-31","value":-2706500000,"profit":false},{"date":"2020-12-31","value":-1654400000,"profit":false},{"date":"2021-12-31","value":-5159900000,"profit":false},{"date":"2022-12-31","value":-6345100000,"profit":false},{"date":"2023-12-31","value":-6609900000,"profit":false}]
Total Non-Operating Income/Expense891.00K(185.00K)(1.82M)354.00K(2.85M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-20.76,"profit":false},{"date":"2021-12-31","value":-204.83,"profit":false},{"date":"2022-12-31","value":39.73,"profit":true},{"date":"2023-12-31","value":-319.64,"profit":false}]
Pre-Tax Income(26.59M)(16.67M)(53.05M)(63.27M)(67.88M)[{"date":"2019-12-31","value":-2658700000,"profit":false},{"date":"2020-12-31","value":-1666800000,"profit":false},{"date":"2021-12-31","value":-5304700000,"profit":false},{"date":"2022-12-31","value":-6327400000,"profit":false},{"date":"2023-12-31","value":-6788300000,"profit":false}]
Income Taxes10.00K35.00K41.00K70.00K(33.91M)[{"date":"2019-12-31","value":14.29,"profit":true},{"date":"2020-12-31","value":50,"profit":true},{"date":"2021-12-31","value":58.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-48447.14,"profit":false}]
Income After Taxes(26.60M)(16.70M)(53.09M)(63.34M)(33.97M)[{"date":"2019-12-31","value":-2659700000,"profit":false},{"date":"2020-12-31","value":-1670300000,"profit":false},{"date":"2021-12-31","value":-5308800000,"profit":false},{"date":"2022-12-31","value":-6334400000,"profit":false},{"date":"2023-12-31","value":-3397000000,"profit":false}]
Income From Continuous Operations(26.59M)(16.70M)(53.09M)(63.34M)(71.17M)[{"date":"2019-12-31","value":-2658700000,"profit":false},{"date":"2020-12-31","value":-1670300000,"profit":false},{"date":"2021-12-31","value":-5308800000,"profit":false},{"date":"2022-12-31","value":-6334400000,"profit":false},{"date":"2023-12-31","value":-7117000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(26.60M)(16.70M)(53.09M)(63.34M)(33.97M)[{"date":"2019-12-31","value":-2659700000,"profit":false},{"date":"2020-12-31","value":-1670300000,"profit":false},{"date":"2021-12-31","value":-5308800000,"profit":false},{"date":"2022-12-31","value":-6334400000,"profit":false},{"date":"2023-12-31","value":-3397000000,"profit":false}]
EPS (Diluted)(0.11)(0.12)(0.63)(1.28)(1.33)[{"date":"2019-12-31","value":-11.41,"profit":false},{"date":"2020-12-31","value":-11.94,"profit":false},{"date":"2021-12-31","value":-62.5,"profit":false},{"date":"2022-12-31","value":-128,"profit":false},{"date":"2023-12-31","value":-133,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RANI
Cash Ratio 1.50
Current Ratio 1.60

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RANI
ROA (LTM) -56.83%
ROE (LTM) -225.35%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RANI
Debt Ratio Lower is generally better. Negative is bad. 0.87
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.07

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RANI
Trailing PE NM
Forward PE NM
P/S (TTM) 313.17
P/B 15.05
Price/FCF NM
EV/R 84.28
EV/Ebitda NM

FAQs

What is Rani Therapeutics Holdings Inc share price today?

Rani Therapeutics Holdings Inc (RANI) share price today is $1.42

Can Indians buy Rani Therapeutics Holdings Inc shares?

Yes, Indians can buy shares of Rani Therapeutics Holdings Inc (RANI) on Vested. To buy Rani Therapeutics Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RANI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Rani Therapeutics Holdings Inc be purchased?

Yes, you can purchase fractional shares of Rani Therapeutics Holdings Inc (RANI) via the Vested app. You can start investing in Rani Therapeutics Holdings Inc (RANI) with a minimum investment of $1.

How to invest in Rani Therapeutics Holdings Inc shares from India?

You can invest in shares of Rani Therapeutics Holdings Inc (RANI) via Vested in three simple steps:

  • Click on Sign Up or Invest in RANI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Rani Therapeutics Holdings Inc shares
What is Rani Therapeutics Holdings Inc 52-week high and low stock price?

The 52-week high price of Rani Therapeutics Holdings Inc (RANI) is $8.75. The 52-week low price of Rani Therapeutics Holdings Inc (RANI) is $1.3.

What is Rani Therapeutics Holdings Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Rani Therapeutics Holdings Inc (RANI) is

What is Rani Therapeutics Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Rani Therapeutics Holdings Inc (RANI) is 15.05

What is Rani Therapeutics Holdings Inc dividend yield?

The dividend yield of Rani Therapeutics Holdings Inc (RANI) is 0.00%

What is the Market Cap of Rani Therapeutics Holdings Inc?

The market capitalization of Rani Therapeutics Holdings Inc (RANI) is $81.97M

What is Rani Therapeutics Holdings Inc’s stock symbol?

The stock symbol (or ticker) of Rani Therapeutics Holdings Inc is RANI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top